Document is current
Any future updates will be listed below
-
Authors
Harkins, Patricia https://orcid.org/0000-0001-7769-6454
Cowley, Sharon https://orcid.org/0000-0002-7788-8322
Burke, Eoghan https://orcid.org/0000-0001-9809-9405
Harrington, Robert
Molloy, Danielle
Kane, David
Conway, Richard https://orcid.org/0000-0003-2538-3362
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 8 September 2025
First Online: 14 October 2025
Declarations
:
: Patricia Harkins reports grant/ research support from Johnson and Johnson and Novartis independent of this article. Sharon Cowley reports grant/ research support from Novartis, independent of this article. Richard Conway reports being a member of speaker’s bureau for Janssen, Roche, Sanofi, AbbVie, Alfasigma, Fresenius Kabi, Viatris, Vifor; undertaking clinical trials funded by AbbVie, Novartis; receiving grant/research support from Janssen, Novartis, Celltrion, Nordic Pharma independent of this article. David Kane reports grant support from Novartis, speaker Honoraria from Janssen and conference attendance support from AbbVie and Janssen, all independent of this article. Eoghan Burke, Robert Harrington and Danielle Molloy declare no conflict of interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
